Skip to Content

Join the 'Baycadron' group to help and get support from people like you.

Baycadron Support Group

Further Information

Related Condition Support Groups

Adrenal Insufficiency, Inflammatory Conditions, Nausea / Vomiting - Chemotherapy Induced, Addison's Disease, Adrenocortical Insufficiency, Hay Fever, Allergic Rhinitis, Aspiration Pneumonia, Asthma, view more... Iritis, Cerebral Edema, Bursitis, Multiple Myeloma, Lymphoma, Mountain Sickness / Altitude Sickness, Epicondylitis - Tennis Elbow, Ulcerative Colitis, Idiopathic (Immune) Thrombocytopenic Purpura, Uveitis (Posterior), Eczema, Adrenogenital Syndrome, Ankylosing Spondylitis, Asthma - Acute, Rheumatoid Arthritis, Mycosis Fungoides, Neurosarcoidosis, Pemphigus, Psoriatic Arthritis, Pulmonary Tuberculosis, Seborrheic Dermatitis, Sarcoidosis, Shock, Synovitis, Systemic Lupus Erythematosus, Thrombocytopenia, Toxic Epidermal Necrolysis, Tuberculous Meningitis, Multiple Sclerosis, Contact Dermatitis, Atopic Dermatitis, Erythroblastopenia, Iridocyclitis, Evan's Syndrome, Gouty Arthritis, Hemolytic Anemia, Hypercalcemia of Malignancy, Dermatitis Herpetiformis, Inflammatory Bowel Disease, Cushing's Syndrome, Croup, Meningitis - Pneumococcal, Chorioretinitis, Keratitis, Leukemia, Loeffler's Syndrome, Bronchopulmonary Dysplasia, Meningitis - Haemophilus influenzae, Meningitis - Listeriosis, Meningitis - Meningococcal, Juvenile Rheumatoid Arthritis

Baycadron Patient Information at

Latest News

Imbruvica Approval Expanded to Include Graft Versus Host Disease

WEDNESDAY, Aug. 2, 2017 – The U.S. Food and Drug Administration on Wednesday expanded approval for the anti-cancer drug Imbruvica (ibrutinib) to include adults with chronic graft versus host disease ...

Read more news...

Ask a Question